SCHEMBL7426521

SCHEMBL7426521

CCCC[CH]c1cccc(Oc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 3/20 0.51
▸ TLR4 O00206 2/20 0.45
▸ TLR2 O60603 2/20 0.45
▸ ALOX5 P09917 3/20 0.45
▸ PTGS1 P23219 2/20 0.45
▸ PTGS2 P35354 2/20 0.45
▸ ALOX5AP P20292 1/20 0.45
▸ LMNA P02545 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ EPOR P19235 2/20 0.43
▸ CETP P11597 1/20 0.43
▸ MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10873829 0.86 LTA4H (0.59) LTA4HTLR4TLR2LMNAMAPT
SCHEMBL11397964 0.86 TLR4 (0.50) LTA4HTLR4TLR2ALOX5PTGS1
SCHEMBL29161712 0.82 MAOB (0.44) LTA4HTLR4TLR2ALOX5PTGS1
SCHEMBL29254135 0.80 ALOX5 (0.48) LTA4HTLR4TLR2ALOX5PTGS1
SCHEMBL160454 0.80 LMNA (0.43) LTA4HPTGS2LMNA
SCHEMBL28049061 0.79 MAOA (0.51) LTA4HTLR4TLR2ALOX5PTGS1
SCHEMBL11442885 0.78 MAPT (0.50) LTA4HTLR4TLR2ALOX5PTGS1
SCHEMBL11304733 0.78 MAPT (0.50) LTA4HTLR4TLR2ALOX5PTGS1
SCHEMBL27693342 0.77 EPOR (0.50) LTA4HTLR4TLR2ALOX5PTGS1
SCHEMBL4141490 0.77 CHRM5 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212306-A2 HYDROXYALKANOYLAMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF ABETA PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2002-06-12 — — EP disclosed
WO-2001019797-A2 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION DU PONT PHARMACEUTICALS COMPANY (US) 2001-03-22 — — WO disclosed
Send feedback